EVOGENE LTDNARY SHARES
EVOGENE LTDNARY SHARES
Action · IL0011050551 · EVGN (XNAS)
Aperçu Indicateurs financiers
1,10 USD
-0,45 % -0,005 USD
NASDAQ (XNAS) · Cours et graphiques actuels sur MoneyPeak
06.06.2025 19:55

Cours actuels de EVOGENE LTDNARY SHARES

BourseTickerDeviseDernier échangeCoursVariation journalière
XNAS: NASDAQ
NASDAQ
EVGN
USD
06.06.2025 19:55
1,10 USD
1,11 USD
-0,45 %

Performance

Jour Semaine Mois 3 mois 6 mois 1 an 5 ans
0,00 % 0,92 % -3,51 % -22,54 % -23,08 % -83,82 % -90,91 %

Profil de l'entreprise pour EVOGENE LTDNARY SHARES Action

Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding of biology leveraged through big data and artificial intelligence, designed to computationally discover and uniquely guide the development of life-science products based on microbes, small molecules, and genetic elements. The company operates through three segments: Agriculture, Human Health, and Industrial Applications. The Agriculture segment develops seed traits, ag-chemical products, and ag-biological products to enhance plant performance. Its products focus on various crops, such as corn, soybean, wheat, rice, and cotton. The Industrial Applications segment develops enhanced castor bean seeds to serve as a feedstock source for other industrial uses. The Human Health segment discovers and develops human microbiome-based therapeutics for the treatment of immuno-oncology, GI related disorders, and antimicrobial resistance organisms. The company also provides medical cannabis products. It operates in the United States, Israel, Brazil, and internationally. The company has strategic collaborations and licensing agreements with agricultural companies, such as BASF SE, Corteva, and Bayer; and through its subsidiary, Canonic Ltd., has a collaboration agreement with Cannbit Ltd. for the development of novel medical cannabis products. Evogene Ltd. was founded in 1999 and is headquartered in Rehovot, Israel.

Données de l'entreprise

Nom EVOGENE LTDNARY SHARES
Société Evogene Ltd.
Symbole EVGN
Site web https://www.evogene.com
Marché d'origine XNAS NASDAQ
ISIN IL0011050551
Type de titre Action
Secteur Healthcare
Industrie Biotechnology
PDG Mr. Ofer Haviv CPA
Pays Israël
Devise USD
Employés 0,1 T
Adresse 13 Gad Feinstein Street, 7414002 Rehovot
Date d'introduction en bourse 2010-10-15

Fractionnements d'actions

Date Fractionnement
25.07.2024 1:10
19.11.2013 1:2

Symboles boursiers

Nom Symbole
NASDAQ EVGN

Autres actions

Les investisseurs qui détiennent EVOGENE LTDNARY SHARES ont également les actions suivantes dans leur portefeuille :
ISL.BALEARES 19/28
ISL.BALEARES 19/28 Obligation
LBBW DL LHA BOA 15/21
LBBW DL LHA BOA 15/21 Obligation
La plateforme financière MoneyPeak suit et analyse les investissements et les portefeuilles. Du dépôt de titres à l'achat de crypto.
Utile, simple et gratuit. Actions, ETF, ETC, ETN, indices, fonds, obligations, certificats, devises, options, droits de souscription.
Mentions légales Protection des données Blog Communauté Retour d'information Changelog
Im App Store herunterladen Bei Google Play herunterladen
Tous droits réservés © LCP GmbH 2025